RESUMEN
Demineralized bone matrix (DBM) powder is widely used for bone regeneration due to its osteoinductivity and osteoconductivity. However, difficulties with handling, tendency to migrate from graft sites and lack of stability after surgery sometimes limit the clinical utility of this material. In this work, the possibility of using sodium alginate (ALG) carrier to deliver DBM powder was assessed. DBM-ALG putty with the DBM:ALG weight ratio of 5:5, 6:4, 7:3, 8:2 were prepared, respectively. The properties of the formed composite, including discrete degree, washout property, pH, equilibrium swelling as well as cytotoxicity in vivo, were adopted to ascertain the optimal ratio of DBM and ALG. The discrete diameter increased from 1.25 cm (5:5) to 2.08 cm (8:2) with the increase of DBM content. There was significant difference between the 8:2 group and the other groups in discrete diameter. The ratio of DBM had a significant effect on the swelling value. The pH of composites showed an increase trend with the DBM ratio's increase, when the ratio reached 7:3, the pH (7.22) was approximately equal to the body fluid. The proliferation of MC3T3-E1 cells was inhibited in the 5:5, 6:4 and 7:3 groups, while a slightly increased in the 8:2 group. The DBM-ALG with the optimal ratio of 7:3 was confirmed based on the results of the above mentioned. The histocompatibility of DBM-ALG (7:3) was examined using a rat model in which the materials were implanted subcutaneously, compared with the polyethylene, ALG and DBM. The study in vivo showed DBM-ALG (7:3) had a lower inflammatory response than DBM, a higher vascularization than ALG. The osteoinduction of DBM-ALG (7:3) was evaluated by co-culturing with MC3T3-E1 in vitro, compared with the DMEM, ALG and DBM. The results indicated calcification area in the DBM-ALG group was similar to that in the DBM group, larger than ALG group and DMEM group. The DBM-ALG (7:3) putty is promising as a directly injectable graft for repair of bone defect.
Asunto(s)
Alginatos/química , Matriz Ósea/química , Matriz Ósea/trasplante , Sustitutos de Huesos/química , Minerales/aislamiento & purificación , Alginatos/toxicidad , Animales , Regeneración Ósea , Sustitutos de Huesos/toxicidad , Calcificación Fisiológica , Línea Celular , Proliferación Celular , Ácido Glucurónico/química , Ácido Glucurónico/toxicidad , Ácidos Hexurónicos/química , Ácidos Hexurónicos/toxicidad , Concentración de Iones de Hidrógeno , Masculino , Ensayo de Materiales , Ratones , Ratas WistarRESUMEN
Coral is used worldwide for bone reconstruction. The favorable characteristics that make this material desirable for implantation are (i) osteoinduction, (ii) and osteoconduction. These proprieties have been demonstrated by in vivo studies with animal models and clinical trials over a twenty-year period. Also poly(2-hydroxyethylmethacrylate) [poly(HEMA)] is a widely used biomaterial. By using coral and poly(HEMA), a scaffold for bone reconstruction application has been recently synthesized. Cytological, histological and genetic analyses were performed to characterize this new alloplastic material. Four samples were analyzed: (a) white coral (WC), (b) red coral (RC), (c) WC plus polymer (WCP) and (d) RC plus polymer (RCP). Quantification of mitochondrial dehydrogenase activity by MTT assay was performed as indirect detector of cytotoxicity. In vivo effects were revealed by implanting corals and coral-based polymers in rabbit tibia. Samples were collected after 4 weeks and subjected to histological analysis. To evaluate the genetic response of cells to corals and coral-derived polymers an osteoblastlike cell line (i.e. MG63) was cultured in wells containing (a) medium, (b) medium plus corals and (c) medium plus two types of scaffolds (RCP or WCP). RNAs extracted from cells were retro-transcribed and hybridized on DNA 19.2K microarrays. No cytotoxicity was detected in corals and coral-based biopolymers. No inflammation or adverse effect was revealed by histological examination. By microarray analysis 154 clones were differentially expressed between RC and WC (81 up and 73 down regulated) whereas only 15 clones were repressed by the polymer. Histological evaluation not only confirmed that coral is a biocompatible material, but also that the polymer has no adverse effect. Microarray results were in agreement with cytological and histological analyses and provided further data regarding the genetic effects of RC, WC and the new polymer.
Asunto(s)
Antozoos , Materiales Biocompatibles , Sustitutos de Huesos , Oseointegración , Poliaminas , Polihidroxietil Metacrilato/análogos & derivados , Tibia/cirugía , Andamios del Tejido , Animales , Materiales Biocompatibles/toxicidad , Sustitutos de Huesos/toxicidad , Línea Celular Tumoral , Perfilación de la Expresión Génica/métodos , Regulación de la Expresión Génica , Humanos , Ensayo de Materiales , Modelos Animales , Análisis de Secuencia por Matrices de Oligonucleótidos , Oseointegración/genética , Osteoblastos/metabolismo , Poliaminas/toxicidad , Polihidroxietil Metacrilato/toxicidad , Conejos , Tibia/metabolismo , Factores de TiempoRESUMEN
Cytocompatibility of 5 coral aquaculture skeleton species derived from two families (Acroporidae and Pocilloporidae) was studied over the course of in vitro culturing in continuous human fibroblast culture by the MMT test. Biocompatibility and capacity of scaffold to "transfer" cell cultures (specifically, multipotent mesenchymal stromal cells) to sites of implantation were studied in vivo by subcutaneous implantation of skeletal fragments to rats. All coral skeleton aquaculture specimens were cytocompatible (nontoxic and with surface matrix characteristics satisfactory for cells), biocompatible, and could be tried as 3D matrices for bone tissue engineering.
Asunto(s)
Antozoos , Regeneración Ósea , Sustitutos de Huesos/toxicidad , Andamios del Tejido , Animales , Técnicas de Cultivo de Célula , Supervivencia Celular , Células Cultivadas , Fibroblastos/fisiología , Humanos , Masculino , Ensayo de Materiales , Células Madre Mesenquimatosas/fisiología , Prótesis e Implantes , Ratas WistarRESUMEN
OBJECTIVE: Synthetic calcium phosphate bone substitutes are widely used in sinus graft procedures due to their osteoconductive and biocompatible properties. Hydroxyapatite (HA), beta-tricalcium phosphate (ß-TCP), and HA/ß-TCP composite are the most applied materials. The aim of this study was to propose a new mineralogical formulation, HA/tetracalcium phosphate (TTCP), as biomaterial for bone regeneration in the maxillary sinus. METHODS: Sinus grafts were performed by using granules of a HA/TTCP blend and a collagen membrane. Bone response at time points of 14 and 17 weeks was histologically evaluated. RESULTS: After 14 weeks of healing, histomorphometric analysis showed the formation of new bone trabeculae among HA/TTCP granules. After 17 weeks, the bone trabeculae were thicker and HA/TTCP granules were still present. Histomorphometric analysis revealed a bone graft contact (BGC) of 64%. CONCLUSIONS: After 17 weeks from implantation, HA/TTCP synthetic bone graft performed very well as osteoconductive material: BGC was found very high, and bone volume and vital bone showed an ideal bone density for implant placement. HA/TTCP granules are accounted for to accelerate new bone formation and to reduce the time needed for the graft healing, thus achieving high quantity of the new bone formed.
Asunto(s)
Sustitutos de Huesos/uso terapéutico , Fosfatos de Calcio/uso terapéutico , Durapatita/uso terapéutico , Elevación del Piso del Seno Maxilar/métodos , Animales , Células 3T3 BALB , Densidad Ósea/fisiología , Matriz Ósea/patología , Regeneración Ósea/fisiología , Remodelación Ósea/fisiología , Sustitutos de Huesos/química , Sustitutos de Huesos/toxicidad , Fosfatos de Calcio/química , Fosfatos de Calcio/toxicidad , Colágeno , Durapatita/química , Durapatita/toxicidad , Macaca fascicularis , Maxilar/patología , Membranas Artificiales , Ratones , Microscopía Electrónica de Rastreo , Modelos Animales , Oseointegración/fisiología , Osteogénesis/fisiología , Proyectos Piloto , Porosidad , Difracción de Rayos XRESUMEN
OBJECTIVE: To determine the mechanisms involved in inflammatory responses to octacalcium phosphate (OCP) crystals in vivo. METHODS: OCP crystal-induced inflammation was monitored using a peritoneal model of inflammation in mice with different deficiencies affecting interleukin-1 (IL-1) secretion (IL-1α(-/-) , IL-1ß(-/-) , ASC(-/-) , and NLRP3(-/-) mice) or in mice pretreated with IL-1 inhibitors (anakinra [recombinant IL-1 receptor antagonist] and anti-IL-1ß). The production of IL-1α, IL-1ß, and myeloid-related protein 8 (MRP-8)-MRP-14 complex was determined by enzyme-linked immunosorbent assay. Peritoneal neutrophil recruitment and cell viability were determined by flow cytometry. Depletion of mast cells or resident macrophages was performed by pretreatment with compound 48/80 or clodronate liposomes, respectively. RESULTS: OCP crystals induced peritoneal inflammation, as demonstrated by neutrophil recruitment and up-modulation of IL-1α, IL-1ß, and MRP-8-MRP-14 complex, to levels comparable with those induced by monosodium urate monohydrate crystals. This OCP crystal-induced inflammation was both IL-1α- and IL-1ß-dependent, as shown by the inhibitory effects of anakinra and anti-IL-1ß antibody treatment. Accordingly, OCP crystal stimulation resulted in milder inflammation in IL-1α(-/-) and IL-1ß(-/-) mice. Interestingly, ASC(-/-) and NLRP3(-/-) mice did not show any alteration in their inflammation status in response to OCP crystals. Depletion of the resident macrophage population resulted in a significant decrease in crystal-induced neutrophil infiltration and proinflammatory cytokine production in vivo, whereas mast cell depletion had no effect. Finally, OCP crystals induced apoptosis/necrosis of peritoneal cells in vivo. CONCLUSION: These data indicate that macrophages, rather than mast cells, are important for initiating and driving OCP crystal-induced inflammation. Additionally, OCP crystals induce IL-1-dependent peritoneal inflammation without requiring the NLRP3 inflammasome.
Asunto(s)
Sustitutos de Huesos/toxicidad , Fosfatos de Calcio/toxicidad , Proteínas Portadoras/metabolismo , Interleucina-1/metabolismo , Peritonitis/inducido químicamente , Animales , Conservadores de la Densidad Ósea/farmacología , Supervivencia Celular/efectos de los fármacos , Ácido Clodrónico/farmacología , Cristalización , Modelos Animales de Enfermedad , Femenino , Inyecciones Intraperitoneales , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/patología , Masculino , Mastocitos/efectos de los fármacos , Mastocitos/patología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Proteína con Dominio Pirina 3 de la Familia NLR , Neutrófilos/efectos de los fármacos , Neutrófilos/patología , Peritoneo/efectos de los fármacos , Peritoneo/patología , Peritonitis/metabolismo , Peritonitis/patología , p-Metoxi-N-metilfenetilamina/farmacologíaRESUMEN
Hydroxyapatite-bioglass (HA BG) and hydroxyapatite-ethyl vinyl acetate (HA EVA) are two composite materials that have been developed for bone substitution. Their activity on antioxidant defense mechanism and genotoxicity has not been investigated before. To further confirm its biocompatibility, the present study was undertaken to investigate the effect of HA BG and HA EVA on mice liver antioxidant mechanism along with chromosomal aberrations in human lymphocytes. Physiological saline extract of HA BG and HA EVA showed no adverse effect on liver antioxidant mechanism compared to the cyclophosphamide (CP)-induced toxicity on mice liver homogenate. The results were judged from the in vitro studies made on reduced glutathione, glutathione reductase and lipid peroxidation. These results were well supported by CP- and mytomycin C (MC)-induced genotoxicity studies on human lymphocytes in the presence and absence of a metabolic activator (S9). Hence, it was suggested that these tests could be considered for preliminary toxicological screening of materials intended for clinical applications ahead of in vivo animal model evaluation.
Asunto(s)
Antioxidantes/metabolismo , Sustitutos de Huesos/toxicidad , Cerámica/toxicidad , Aberraciones Cromosómicas/inducido químicamente , Hidroxiapatitas/toxicidad , Hígado/efectos de los fármacos , Ensayo de Materiales/métodos , Compuestos de Vinilo/toxicidad , Animales , Sustitutos de Huesos/química , Cerámica/química , Mezclas Complejas/aislamiento & purificación , Mezclas Complejas/toxicidad , Glutatión/metabolismo , Glutatión Reductasa/metabolismo , Humanos , Hidroxiapatitas/química , Técnicas In Vitro , Peroxidación de Lípido/efectos de los fármacos , Hígado/enzimología , Hígado/metabolismo , Linfocitos/efectos de los fármacos , Linfocitos/patología , Ratones , Compuestos de Vinilo/químicaRESUMEN
PURPOSE: To evaluate the biomechanical properties and biocompatibility of natural hydroxyapatite/chitosan (HA/CS) composites. METHODS: The natural HA/CS composites with a different proportion of HA and CS were prepared by the cross-linking method, and then the compressive strength, microstructure and pH values of extracts from these composites were measured by SEM and pH meter, respectively. Subsequently, the biocompatibility of the composites was evaluated by means of a series of biological tests, including MTT, acute systemic toxicity, heat source, and hemolysis tests in vitro. RESULTS: The chitosan content in the composites had significantly influenced the mechanical properties and microstructure of the composites. The pH value of the composite extract was approximately 7.0, which was very close to that of human plasma. Furthermore, the natural HA/CS composites showed no cytotoxicity, irritation, teratogenicity, carcinogenicity and special pyrogen. CONCLUSIONS: These results indicated that the natural HA/CS composite may be a potential bone repair material.
Asunto(s)
Materiales Biocompatibles/uso terapéutico , Sustitutos de Huesos/química , Sustitutos de Huesos/uso terapéutico , Huesos/efectos de los fármacos , Quitosano/uso terapéutico , Durapatita/uso terapéutico , Fibroblastos/efectos de los fármacos , Animales , Materiales Biocompatibles/química , Materiales Biocompatibles/toxicidad , Sustitutos de Huesos/toxicidad , Línea Celular , Supervivencia Celular/efectos de los fármacos , Quitosano/química , Quitosano/toxicidad , Fuerza Compresiva , Durapatita/química , Durapatita/toxicidad , Fibroblastos/citología , Humanos , Técnicas In Vitro , Ensayo de Materiales , Ratones , Conejos , PorcinosRESUMEN
In the present study, ß-tricalcium phosphate (ß-TCP) scaffolds with various amounts of bredigite (Bre) were fabricated by the space holder method. The effect of bredigite content on the structure, mechanical properties,in vitrobioactivity, and cell viability was investigated. The structural assessment of the composite scaffolds presented interconnected pores with diameter of 300-500 µm with around 78%-82% porosity. The results indicated that the compressive strength of the scaffolds with 20% bredigite (1.91 MPa) was improved in comparison with scaffolds with 10% bredigite (0.52 MPa), due to the reduction of the average pore and grain sizes. Also, the results showed that the bioactivity and biodegradability of ß-TCP/20Bre were better than that of ß-TCP/10Bre. Besides, in this study, the release kinetics of ciprofloxacin (CPFX) loaded ß-TCP/Bre composites as well as the ability of scaffolds to function as a sustained release drug carrier was investigated. Drug release pattern of ß-TCP/bredigite-5CPFX scaffolds exhibited the rapid burst release of 43% for 3 h along with sustained release (82%) for 32 h which is favorable for bone infection treatment. Antibacterial tests revealed that the antibacterial properties of ß-TCP/bredigite scaffolds are strongly related to the CPFX concentration, wherein the scaffold containing 5% CPFX showed the most significant zone of inhibition (33 ± 0.5 mm) againstStaphylococcus aureus. The higher specific surface areas of nanostructure ß-TCP/bredigite scaffolds containing CPFX lead to an initial rapid release followed by constant drug delivery. MTT assay showed that the cell viability of ß-TCP/bredigite scaffold loading with up to 1%-3% CPFX (95 ± 2%), is greater than for scaffolds containing 5% CPFX (84 ± 2%). In Overall, it may suggested that ß-TCP/bredigite containing 1%-3% CPFX possesses great cell viability and antibacterial activity and be employed as bactericidal biomaterials and bone infection treatment.
Asunto(s)
Asbestos Anfíboles , Sustitutos de Huesos , Fosfatos de Calcio , Ciprofloxacina , Andamios del Tejido/química , Antibacterianos/química , Antibacterianos/farmacocinética , Antibacterianos/farmacología , Asbestos Anfíboles/química , Asbestos Anfíboles/farmacocinética , Asbestos Anfíboles/farmacología , Regeneración Ósea/efectos de los fármacos , Sustitutos de Huesos/química , Sustitutos de Huesos/farmacocinética , Sustitutos de Huesos/farmacología , Sustitutos de Huesos/toxicidad , Huesos/citología , Fosfatos de Calcio/química , Fosfatos de Calcio/farmacocinética , Fosfatos de Calcio/farmacología , Línea Celular , Supervivencia Celular/efectos de los fármacos , Ciprofloxacina/química , Ciprofloxacina/farmacocinética , Ciprofloxacina/farmacología , Humanos , Porosidad , Ingeniería de TejidosRESUMEN
Many commercial bone grafts cannot regenerate healthy bone in place of diseased bone. Bioactive glasses have received much attention in this regard due to the ability of their ionic dissolution products to promote cell proliferation, cell differentiation and activate gene expression. Through the incorporation of certain ions, bioactive glasses can become therapeutic for specific pathological situations. Calcium-strontium-sodium-zinc-silicate glass bone grafts have been shown to release therapeutic levels of zinc and strontium, however the in vitro compatibility of these materials is yet to be reported. In this study, the in vitro cytocompatibility of three different calcium-strontium-sodium-zinc-silicate glasses was examined as a function of their ion release profiles, using Novabone® bioglass as a commercial comparison. Experimental compositions were shown to release Si(4+) ranging from 1 to 81 ppm over 30 days; comparable or enhanced release in comparison to Novabone. The maximum Ca(2+) release detected for experimental compositions was 9.1 ppm, below that reported to stimulate osteoblasts. Sr(2+) release was within known therapeutic ranges, and Zn(2+) release ranged from 0.5 to 1.4 ppm, below reported cytotoxic levels. All examined glass compositions show equivalent or enhanced in vitro compatibility in comparison to Novabone. Cells exposed to BT112 ionic products showed enhanced cell viabilities indicating cell proliferation was induced. The ion release profiles suggest this effect was due to a synergistic interaction between certain combinations and concentrations of ions. Overall, results indicate that the calcium-strontium-sodium-zinc-silicate glass compositions show equivalent or even enhanced in vitro compatibility compared to Novabone®.
Asunto(s)
Materiales Biocompatibles/química , Sustitutos de Huesos/química , Vidrio/química , Animales , Materiales Biocompatibles/toxicidad , Regeneración Ósea , Sustitutos de Huesos/toxicidad , Calcio , Cationes/análisis , Cationes/química , Línea Celular , Supervivencia Celular/efectos de los fármacos , Cerámica , Humanos , Técnicas In Vitro , Ensayo de Materiales , Ratones , Silicio , Sodio , Estroncio , ZincRESUMEN
CaO-SiO(2)-P(2)O(5)-B(2)O(3) glass ceramics directly bond to bone and have potential use as a bone substitute material. The present study evaluated the toxicity from subchronic intravenous administration of CaO-SiO(2)-P(2)O(5)-B(2)O(3) glass ceramics to male and female Sprague-Dawley rats. The rats were divided into four groups, each consisting of 10 male and 10 female rats, and administered different amounts of CaO-SiO(2)-P(2)O(5)-B(2)O(3) glass ceramics (aqueous extract 5, 2.5, and 1.25 mL/kg body weight/day and saline) 7 days per week for 90 consecutive days. During the experiment, no deaths were observed in any groups, and there were no remarkable changes in clinical signs, body weight, food and water intake, hematological and serum biochemical parameters, organ weight, and histopathological findings between the control and treated groups. The results show no adverse toxic effects of CaO-SiO(2)-P(2)O(5)-B(2)O(3) glass ceramics (aqueous extract 5 mL/kg body weight/day) to rats of either sex.
Asunto(s)
Sustitutos de Huesos/toxicidad , Compuestos de Boro/química , Cerámica/toxicidad , Animales , Sustitutos de Huesos/administración & dosificación , Sustitutos de Huesos/química , Cerámica/química , Relación Dosis-Respuesta a Droga , Femenino , Inyecciones Intravenosas , Masculino , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Pruebas de ToxicidadRESUMEN
Calcium sulfate (CS) bone cements have been used as bone substitutes for a long time, but their clinical use is currently limited due to their rapid degradation rate and brittleness. This work aimed to study the effect of α-tricalcium phosphate (α-TCP) and silk fibroin nanofibers (SFF) on CS bone cements. The bone cements were prepared from α-CS hemihydrate (α-CSH), calcium sulfate dihydrate (CSD; as a setting accelerator) and varying α-TCP contents (0%, 5%, 10%, 15%, 20% and 25%), with SFF solution or deionized water as the solidification solution at the same liquid/solid ratio. Scanning electron microscopy, particle size distribution, x-ray diffraction and Fourier transform infrared spectroscopy were used to measure the composition and characterize the properties of the materials. The compressive strength, setting time and weight loss rate of samples were also tested. Cytotoxicity was evaluated by a Cell Counting Kit-8 assay. The results suggest that the tuning of α-TCP and SFF has an important role in determining the compressive strength and degradation rate of CS bone cements, and the properties could be changed by varying the content of α-TCP. Moreover, cell experiments showed no toxicity of the samples towards MC3T3 cells. Thus, the materials prepared from α-CSH, CSD, α-TCP and SFF in this work could provide the basis for research into CS-based bone repair materials.
Asunto(s)
Cementos para Huesos/química , Fosfatos de Calcio/química , Sulfato de Calcio/química , Fibroínas/química , Células 3T3 , Implantes Absorbibles/efectos adversos , Animales , Ingeniería Biomédica , Cementos para Huesos/toxicidad , Sustitutos de Huesos/química , Sustitutos de Huesos/toxicidad , Fosfatos de Calcio/toxicidad , Sulfato de Calcio/toxicidad , Proliferación Celular/efectos de los fármacos , Fuerza Compresiva , Fibroínas/toxicidad , Humanos , Ensayo de Materiales , Ratones , Microscopía Electrónica de Rastreo , Nanofibras/química , Nanofibras/toxicidad , Nanofibras/ultraestructura , Tamaño de la Partícula , Espectroscopía Infrarroja por Transformada de Fourier , Propiedades de Superficie , Difracción de Rayos XRESUMEN
The unsaturated polyphosphoester (UPPE) polymer is being investigated as an injectable and biodegradable system for alveolar bone repair in the treatment of periodontal diseases. The incorporation of beta-tricalcium phosphate (beta-TCP) particles into the UPPE polymer was previously shown to significantly increase the material's mechanical properties. Moreover, in vitro experiments demonstrated that the UPPE/beta-TCP composite was capable of zero-order release of tetracycline for over 2 weeks. In this study, we investigated the in vitro cytotoxicity of each individual component, the resulting cross-linked network and the degradation products of the UPPE/beta-TCP composite using an AlamarBlue viability assay. We confirmed that each individual component except beta-TCP and the in vitro degradation products of the composite displayed a dose-dependent cytotoxic response. Once cross-linked, however, the composite did not demonstrate an adverse response. Our results suggest that the UPPE/beta-TCP composite holds great promise for use as an injectable and biodegradable alveolar bone substitute.
Asunto(s)
Implantes Absorbibles , Sustitutos de Huesos/toxicidad , Fosfatos de Calcio/toxicidad , Organofosfatos/toxicidad , Poliésteres/toxicidad , Pérdida de Hueso Alveolar/cirugía , Animales , Sustitutos de Huesos/administración & dosificación , Sustitutos de Huesos/química , Fosfatos de Calcio/administración & dosificación , Fosfatos de Calcio/química , Línea Celular , Supervivencia Celular/efectos de los fármacos , Fibroblastos/efectos de los fármacos , Ratones , Organofosfatos/administración & dosificación , Organofosfatos/química , Poliésteres/administración & dosificación , Poliésteres/químicaRESUMEN
The aim of the present in vitro study was to evaluate the influence of different bone substitute materials (BSM) on the viability of human primary osteoblasts (PO), bone marrow mesenchymal cells (BMMC), and nonadherent myelomonocytic cells (U937). Six different bone substitute materials were tested: Bio-Oss Spongiosa (BOS), Tutodent Chips (TC), PepGen P-15 (P-15), Ostim (OM), BioBase (BB), and Cerasorb (CER). Cells were cultivated on comparable volumes of BSM in 96-well plates. Cell culture-treated polystyrol (Nunclon Delta surface; C) served as positive control. After 2 h and 3, 6, 10, and 14 days, viability of cells was evaluated using a standardized ATP viability assay (CellTiter Glo). Nonsurface-dependent effects of the materials were separately tested using nonadherent U937 suspension cells. For statistical analysis, the Mann-Whitney test was used. Results were considered statistically significant at P < 0.05. Cell viability of PO increased significantly on TC, C, and CER followed by BB. No changes were found for P-15 and decreasing viability for BOS and OM. BMMC showed similar results on C, TC, CER, and P-15. Lower viability for BB and no viability could be detected for BOS and OM (Mann-Whitney test, respectively). Nonadherent cells displayed increasing viability in presence of CER, BB, and BOS. No changes were observed for TC and P-15, whereas for OM, no viability was detected after a maximum cultivation period of 3 days. It was concluded that granular hydroxyapatite (HA; TC, BOS, P-15) and alpha- and beta-tricalciumphosphate (CER, BB) support, whereas nanosized HA (OM) limit or even inhibit surface- and nonsurface-related cell viability in the in vitro model used.
Asunto(s)
Células de la Médula Ósea/efectos de los fármacos , Sustitutos de Huesos/toxicidad , Supervivencia Celular/efectos de los fármacos , Células Madre Mesenquimatosas/efectos de los fármacos , Osteoblastos/efectos de los fármacos , Células Cultivadas , Humanos , Propiedades de Superficie , Células U937/efectos de los fármacosRESUMEN
INTRODUCTION: In the past decade, there has been an increase focus on regeneration approaches as related to periodontics and implant therapies. The main objective of the present study is the evaluation of quality, density, and thickness of the newly formed bone in experimental defects treated with deproteinized bovine bone mineral (DBBM) and bioapatite-collagen. MATERIALS: Fifteen identical cuboidal defects were prepared in the alveolar edentulous mandibular ridges in 10 male sheep. Defects were randomly assigned to be treated either with DBBM, Bioapatite-collagen or remained unfilled as the control group. Defects of these 3 groups were histologically examined after 6 months. RESULTS: The mean percentages of bone regeneration with DBBM, Bioapatite-collagen, and control group were 51.40% +/- 3.57%, 27.66% +/- 4.18%, and 19% +/- 1%, respectively (P < 0.05). Defects filled with Bio-Oss and control defects did not show foreign body reaction, whereas Biostite particles had a reaction in 40% of the specimens. Trabecular thickness and type of new regenerated bone were also significantly different between Bio-Oss and Biostite (P < 0.05) and control group (P < 0.05). CONCLUSION: The results of the present study suggest that using of DBBM particles can promote bone regeneration more effectively than Bioapatite-collagen, and both materials were more promising than the control group.
Asunto(s)
Regeneración Ósea/efectos de los fármacos , Sustitutos de Huesos/farmacología , Colágeno/farmacología , Reacción a Cuerpo Extraño/inducido químicamente , Glicosaminoglicanos/farmacología , Hidroxiapatitas/farmacología , Minerales/farmacología , Animales , Sustitutos de Huesos/toxicidad , Bovinos , Colágeno/toxicidad , Glicosaminoglicanos/toxicidad , Hidroxiapatitas/toxicidad , Masculino , Mandíbula/cirugía , Ensayo de Materiales , Minerales/toxicidad , Distribución Aleatoria , Oveja DomésticaRESUMEN
Porous nano-hydroxyapatite/polyamide 66 (n-HA/PA66) composite was developed by injection molding method. Uniformly distributed and interconnected pores with an average size of about 500 microm in matrix were obtained. The evaluation of biological safety of the porous composite including cell cytoxicity test, sensitivity test, pyrogen test, haemolysis test was carried out according to GB/T16886 and GB/T16175. The results showed that the porous n-HA/PA66 composite was of no cytotoxicity, no allergen and pyrogen reactions as well as no hemolytic effect.
Asunto(s)
Sustitutos de Huesos/síntesis química , Sustitutos de Huesos/toxicidad , Durapatita/química , Ensayo de Materiales , Nylons/química , Animales , Cobayas , Implantes Experimentales , Ratones , Nanocompuestos/química , Nanopartículas/química , Porosidad , Conejos , Ingeniería de TejidosRESUMEN
Essential oils play an important role in reducing the pain and inflammation caused by bone fracture.In this study, a scaffold was electrospun based on polyurethane (PU), grape seed oil, honey and propolis for bone tissue-engineering applications. The fiber diameter of the electrospun PU/grape seed oil scaffold and PU/grape seed oil/honey/propolis scaffold were observed to be reduced compared to the pristine PU control. FTIR analysis revealed the existence of grape seed oil, honey and propolis in PU identified by CH band peak shift and also hydrogen bond formation. The contact angle of PU/grape seed oil scaffold was found to increase owing to hydrophobic nature and the contact angle for the PU/grape seed/honey oil/propolis scaffold were decreased because of hydrophilic nature. Further, the prepared PU/grape seed oil and PU/grape seed oil/honey/propolis scaffold showed enhanced thermal stability and reduction in surface roughness than the control as revealed in thermogravimetric analysis (TGA) and atomic force microscopy (AFM) analysis. Further, the developed nanocomposite scaffold displayed delayed blood clotting time than the pristine PU in the activated prothrombin time (APTT) and partial thromboplastin time (PT) assay. The hemolytic assay and cytocompatibility studies revealed that the electrospun PU/grape seed oil and PU/grape seed oil/honey/propolis scaffold possess non-toxic behaviour to red blood cells (RBC) and human fibroblast cells (HDF) cells indicating better blood compatibility and cell viability rates. Hence, the newly developed electrospun nanofibrous composite scaffold with desirable characteristics might be used as an alternative candidate for bone tissue engineering applications.
Asunto(s)
Materiales Biocompatibles/química , Regeneración Ósea , Sustitutos de Huesos/química , Huesos/fisiología , Ingeniería de Tejidos/métodos , Materiales Biocompatibles/toxicidad , Sustitutos de Huesos/toxicidad , Línea Celular , Supervivencia Celular , Eritrocitos , Fibroblastos , Extracto de Semillas de Uva/química , Extracto de Semillas de Uva/toxicidad , Miel , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Ensayo de Materiales/métodos , Microscopía de Fuerza Atómica , Microscopía Electrónica de Rastreo , Nanocompuestos/química , Nanocompuestos/toxicidad , Nanocompuestos/ultraestructura , Tiempo de Tromboplastina Parcial , Tamaño de la Partícula , Poliuretanos/química , Poliuretanos/toxicidad , Própolis/química , Própolis/toxicidad , Espectroscopía Infrarroja por Transformada de Fourier , Pruebas de Toxicidad/métodosRESUMEN
The aim of the present study is to evaluate the effects of intraosseous implantation of silica-based bioactive glass (BG) particles on rat kidney under experimental renal failure. The animals are assigned to one of the two groups: renal failure (RF) and renal failure + bioactive glass (RF + BG). Particles of melt-derived 45S5 BG are implanted in the marrow of one tibia of each animal in the RF + BG group. The animals are killed 24 h and 14 days postimplantation. The RF + BG group exhibits a statistically significant increase in serum urea 24 h postimplantation. The tibiae of the RF + BG group are resected and embedded in methyl-methacrylate resin. Ground sections are analyzed by light microscopy and energy-dispersive X-ray (EDX) analysis. The presence of silicon, calcium, and phosphorus is evaluated in the BG particles. A 55% reduction in silicon content is observed at 14 days postimplantation as compared with that at 24 h.Light microscopy analysis reveals lesions in kidney parenchyma. Hyperplasia associated with nuclear vacuolization in the tubules and a marked thickening of the basal membrane are observed in the renal cortex of the RF + BG animals killed at 24 h postimplantation, but not in those at 14 days. The present results demonstrate reversible renal cell injury in rats exposed to intraosseous implantation of silica-based BG particles under experimental RF.
Asunto(s)
Materiales Biocompatibles/toxicidad , Sustitutos de Huesos/toxicidad , Vidrio/química , Riñón/efectos de los fármacos , Dióxido de Silicio/química , Animales , Materiales Biocompatibles/química , Sustitutos de Huesos/química , Huesos/cirugía , Riñón/patología , Masculino , Ensayo de Materiales , Ratas , Ratas Wistar , Insuficiencia Renal/patologíaRESUMEN
Recently, a modified form of a three-dimension (3D) porous poly(caprolactone-trifumarate) (PCLTF) scaffold has been produced using a fabrication technique that involves gelatin microparticles porogen leaching. This poly(caprolactone trifumarate-gelatin microparticles) (PCLTF-GMPs) scaffold has been shown to be biocompatible, more flowable clinically, and has a shorter degradation time as compared to its existing predecessors. In this report, a detailed characterization of this new scaffold was performed by testing its cytocompatibility, analyzing the surface topography, and understanding its thermal, physical and mechanical properties. The result showed that the PCLTF-GMPs has no critical cytotoxic effect. To confirm improvement, the surface properties were compared against the older version of PCLTF fabricated using salt porogen leaching. This PCLTF-GMPs scaffold showed no significant difference (unpaired t-test; p>0.05) in mechanical properties before and after gelatin leaching. However, it is mechanically weaker when compared to its predecessors. It has a high biodegradability rate of 16weeks. The pore size produced ranges from 40 to 300µm, and the RMS roughness is 613.7±236.9nm. These characteristics are condusive for osteoblast in-growth, as observed by the extension of filopodia across the macropores. Overall, this newly produced material has good thermal, physical and mechanical properties that complements its biocompatibility and ease of use.
Asunto(s)
Sustitutos de Huesos/química , Gelatina/química , Poliésteres/química , Adsorción , Sustitutos de Huesos/toxicidad , Línea Celular , Supervivencia Celular/efectos de los fármacos , Fuerza Compresiva , Humanos , Microscopía Electrónica de Rastreo , Porosidad , Propiedades de Superficie , Temperatura , Resistencia a la Tracción , Termogravimetría , Ingeniería de Tejidos , Andamios del Tejido , Agua/químicaRESUMEN
Nano-hydroxyapatite (n-HA) reinforced poly(propylene carbonate) (PPC) composites were prepared for bone repair and reconstruction. The effects of reinforcement on the morphology, mechanical properties and biological performance of n-HA/PPC composites were investigated. The surface morphology and mechanical properties of the composites were characterized by scanning electron microscopy (SEM) and universal material testing machine. The analytical data showed that good incorporation and dispersion of n-HA crystals could be obtained in the PPC matrix at a 30:70 weight ratio. With the increase of n-HA content, the tensile strength increased and the fracture elongation rate decreased. In vitro cell culture revealed that the composite was favorable template for cell attachment and growth. In vivo implantation in femoral condyle defects of rabbits confirmed that the n-HA/PPC composite had good biocompatibility and gradual biodegradability, exhibiting good performance in guided bone regeneration. The results demonstrates that the incorporation of n-HA crystals into PPC matrix provides a practical way to produce biodegradable and cost-competitive composites mimicking the osteogenic niche for bone augmentation.
Asunto(s)
Regeneración Ósea/efectos de los fármacos , Sustitutos de Huesos/química , Sustitutos de Huesos/farmacología , Durapatita/química , Fémur/efectos de los fármacos , Nanocompuestos/química , Propano/análogos & derivados , Animales , Sustitutos de Huesos/toxicidad , Adhesión Celular/efectos de los fármacos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Fémur/fisiología , Humanos , Ensayo de Materiales , Propano/química , ConejosRESUMEN
BACKGROUND: Polybutylene succinate (PBSu) and PBSu/ß-tricalcium phosphate (TCP) composites are biocompatible and good candidates as bone graft materials. However, little is known about the responses of T lymphocytes to these biomaterials, which play an important role in the success of bone grafting. METHODS: Activated T lymphocytes were cultured onto 32 mm diameter films (PBSu/TCP films), that had previously been placed in 6-well culture plates, for 8, 24 and 72 hours. A plastic-well culture plate was used as a control surface. The effects of PBSu-based biomaterials on T lymphocytes were examined by the using flow cytometry and reverse-transcription polymerase chain reaction. RESULTS: These biomaterials were non-toxic to T lymphocytes, allowing their normal DNA synthesis and activation. All materials induced only transient activation of T lymphocytes, which existed no longer than 72 hours. Proportions of four main CD4/CD8 T lymphocyte subpopulations were not affected by these biomaterials. Moreover, PBSu and PBSu/TCP significantly suppressed the expression of IL-1ß and IL-6 genes by 15-35% and 21-26%, respectively. In contrast, a PBSu/TCP composite (at PBSu:TCP=60:40) significantly stimulated the expression of IL-10 and IL-13 genes by 17% and 19%, respectively. CONCLUSIONS: PBSu and PBSu/TCP composites were non-toxic to T lymphocytes and did not induce unfavorable responses of T lymphocytes. The tested biomaterials down-regulated key proinflammatory cytokine genes and up-regulated anti-inflammatory cytokine genes in T lymphocytes. These suggest that the biomaterials studied are good candidates as bone graft materials.